We are live on ! Find out more
MEDP icon

Medpace

269 hedge funds and large institutions have $2.1B invested in Medpace in 2020 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 85 increasing their positions, 99 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 31

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

42% more call options, than puts

Call options by funds: $5.06M | Put options by funds: $3.56M

8% more funds holding

Funds holding: 250269 (+19)

1.13% less ownership

Funds ownership: 80.49%79.36% (-1.1%)

14% less capital invested

Capital invested by funds: $2.43B → $2.1B (-$329M)

14% less repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 99

Holders
269
Holders Change
+19
Holders Change %
+7.6%
% of All Funds
5.93%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
52
Increased
85
Reduced
99
Closed
31
Calls
$5.06M
Puts
$3.56M
Net Calls
+$1.49M
Net Calls Change
+$2.86M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$17M -$665K -7,655 -3%
BCA
27
Bernzott Capital Advisors
California
$16.6M -$987K -11,370 -5%
Man Group
28
Man Group
United Kingdom
$16.6M -$12.3M -141,222 -38%
Capital Fund Management (CFM)
29
Capital Fund Management (CFM)
France
$14.2M -$2.87M -33,077 -15%
TCM
30
Tributary Capital Management
Nebraska
$13.3M -$484K -5,573 -3%
Prudential Financial
31
Prudential Financial
New Jersey
$13M +$2.15M +24,774 +16%
JIM
32
Jupiter Investment Management
United Kingdom
$12.5M -$7.02M -80,808 -32%
N
33
Nuveen
North Carolina
$12.2M +$92.4K +1,064 +0.6%
HAM
34
Hillcrest Asset Management
Texas
$11.8M +$92K +1,060 +0.7%
ACM
35
American Capital Management
New York
$11.7M +$13.8M +158,901 New
RI
36
Redwood Investments
Massachusetts
$11.3M -$2.3M -26,467 -15%
Morgan Stanley
37
Morgan Stanley
New York
$10.6M -$5.72M -65,913 -31%
Wells Fargo
38
Wells Fargo
California
$10.5M +$1.38M +15,852 +12%
AQR Capital Management
39
AQR Capital Management
Connecticut
$10.4M +$232K +2,671 +2%
Bank of America
40
Bank of America
North Carolina
$10.2M -$1.14M -13,184 -9%
JP Morgan Chase
41
JP Morgan Chase
New York
$10.1M -$1.93M -22,221 -14%
Russell Investments Group
42
Russell Investments Group
United Kingdom
$9.78M +$1.99M +22,978 +21%
MCM
43
Matarin Capital Management
New York
$9.22M -$903K -10,403 -8%
First Trust Advisors
44
First Trust Advisors
Illinois
$8.39M +$565K +6,503 +6%
Franklin Resources
45
Franklin Resources
California
$8.22M +$9.72M +111,989 New
PI
46
Putnam Investments
Massachusetts
$8.12M -$27.6K -318 -0.3%
SI
47
Scout Investments
Missouri
$6.68M -$461K -5,309 -6%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$6.49M +$128K +1,476 +2%
PPA
49
Parametric Portfolio Associates
Washington
$6.15M -$285K -3,279 -4%
Legal & General Group
50
Legal & General Group
United Kingdom
$5.97M +$139K +1,605 +2%

MEDP Hedge Fund Activity: Q1 2020 in Review

269 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2020, worth a combined $2.1B — down 14% from $2.43B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new MEDP positions and 31 closed out — a net gain of 21 holders — while 85 added to existing stakes and 99 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $42.1M. The largest seller was APG Asset Management, cutting an estimated $35M.

  • 269 institutional investors held Medpace (MEDP) as of Q1 2020, up from 250 in Q4 2019.
  • Funds reported $2.1B of Medpace stock for Q1 2020, down 14% quarter-over-quarter.
  • 52 funds opened new Medpace positions in Q1 2020 and 31 closed out, a net change of +21 holders.
  • The largest Medpace buyer in Q1 2020 was Wasatch Advisors, an estimated $42.1M added.
  • The largest Medpace seller in Q1 2020 was APG Asset Management, an estimated $35M sold.

Based on aggregated 13F filings for Q1 2020.